StockData
Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC) stock

BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3076% below fair value
$8.47+0.05 (+0.59%)

Close on Nov 17, 2026Market cap $3.17BP/E –Yield –

Bausch Health Companies operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Bausch Health Companies's operating cash flow for the twelve months ending Sep 30, 2026 was $2.21B, up 46.7% year over year. For fiscal 2025 it was $1.40B, down 12.3% from the year before. Over ten years it grew -4.7% a year on average. The highest annual figure on record is $2.31B in fiscal 2014.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.40B-12.3%
FY2024Dec 31, 2024$1.60B+54.7%
FY2023Dec 31, 2023$1.03B–
FY2022Dec 31, 2022-$728.00M-151.1%
FY2021Dec 31, 2021$1.43B+28.4%
FY2020Dec 31, 2020$1.11B-26.0%
FY2019Dec 31, 2019$1.50B0.0%
FY2018Dec 31, 2018$1.50B-34.5%
FY2017Dec 31, 2017$2.29B+9.7%
FY2016Dec 31, 2016$2.09B-7.5%
FY2015Dec 31, 2015$2.26B-2.4%
FY2014Dec 31, 2014$2.31B+121.9%
FY2013Dec 31, 2013$1.04B+58.7%
FY2012Dec 31, 2012$656.60M+2.5%
FY2011Dec 31, 2011$640.47M+143.3%
FY2010Dec 31, 2010$263.19M-27.1%
FY2009Dec 31, 2009$360.90M+76.6%
FY2008Dec 31, 2008$204.33M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$814.00M+101.0%
Q2 FY2026Jun 30, 2026$670.00M+131.8%
Q1 FY2026Mar 31, 2026$230.00M+9.0%
Q4 FY2025Dec 31, 2025$495.00M-17.6%
Q3 FY2025Sep 30, 2025$405.00M0.0%
Q2 FY2025Jun 30, 2025$289.00M-23.9%
Q1 FY2025Mar 31, 2025$211.00M0.0%
Q4 FY2024Dec 31, 2024$601.00M+54.1%
Q3 FY2024Sep 30, 2024$405.00M+43.6%
Q2 FY2024Jun 30, 2024$380.00M+84.5%
Q1 FY2024Mar 31, 2024$211.00M+37.0%
Q4 FY2023Dec 31, 2023$390.00M-17.9%
Q3 FY2023Sep 30, 2023$282.00M–
Q2 FY2023Jun 30, 2023$206.00M+67.5%
Q1 FY2023Mar 31, 2023$154.00M–
Q4 FY2022Dec 31, 2022$475.00M+1879.2%
Q3 FY2022Sep 30, 2022-$1.26B-323.9%
Q2 FY2022Jun 30, 2022$123.00M-68.9%
Q1 FY2022Mar 31, 2022-$63.00M-114.2%
Q4 FY2021Dec 31, 2021$24.00M-93.9%
Q3 FY2021Sep 30, 2021$564.00M+120.3%
Q2 FY2021Jun 30, 2021$395.00M+97.5%
Q1 FY2021Mar 31, 2021$443.00M+69.7%
Q4 FY2020Dec 31, 2020$394.00M+68.4%
Q3 FY2020Sep 30, 2020$256.00M-50.3%
Q2 FY2020Jun 30, 2020$200.00M-41.0%
Q1 FY2020Mar 31, 2020$261.00M-36.8%
Q4 FY2019Dec 31, 2019$234.00M-26.6%
Q3 FY2019Sep 30, 2019$515.00M-1.3%
Q2 FY2019Jun 30, 2019$339.00M+52.7%
Q1 FY2019Mar 31, 2019$413.00M-5.7%
Q4 FY2018Dec 31, 2018$319.00M-44.8%
Q3 FY2018Sep 30, 2018$522.00M+6.5%
Q2 FY2018Jun 30, 2018$222.00M-17.2%
Q1 FY2018Mar 31, 2018$438.00M-54.1%
Q4 FY2017Dec 31, 2017$578.00M+12.9%
Q3 FY2017Sep 30, 2017$490.00M–
Q2 FY2017Jun 30, 2017$268.00M–
Q1 FY2017Mar 31, 2017$954.00M–
Q4 FY2016Dec 31, 2016$512.00M–

More Bausch Health Companies figures

See a number that looks wrong?